Arvin Capital Management LP Charles River Laboratories International, Inc. Transaction History

Arvin Capital Management LP

  • $311 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$206.39 - $268.73 $3.75 Million - $4.88 Million
18,157 Added 36.55%
67,838 $14 Billion
Q1 2024

May 14, 2024
BUY
$203.52 - $273.43 $6.03 Million - $8.1 Million
29,620 Added 147.65%
49,681 $13.5 Billion
Q4 2023

Feb 13, 2024
BUY
$164.52 - $238.84 $3.3 Million - $4.79 Million
20,061 New
20,061 $4.74 Billion

Others Institutions Holding CRL

# of Institutions
695
Shares Held
52.2M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.64B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Arvin Capital Management LP Portfolio

Follow Arvin Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvin Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Arvin Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email